Home

Richard R. DeLuca

CIK 1421339 · EVP&Pres, Merck Animal Heallth · last filed 2026-08-12

Richard R. DeLuca is an EVP&Pres, Merck Animal Heallth who has filed 58 SEC Form 4 insider transactions across 2 companies since 2008. The most recent filing, for MRK, was dated Aug 12, 2026. Across all open-market trades the lifetime net is −$71.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $16.8M across reported positions. 53 SEC filings were submitted jointly with Merck & Co., Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$16.76M

Companies

2

Total Filings

58

Lifetime Open-Market Net

-$71.18M

Filer Profile

Reported Address
C/O MERCK & CO., INC.
126 EAST LINCOLN AVENUE
RAHWAY, NJ 07065
Related Filers
Merck & Co., Inc. — 53 joint filings, latest 2026-08-12
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MRK EVP&Pres, Merck Animal Heallth 111,488 $150.33 $16.76M -$71.18M 43 2026-08-12
WYETH (WYE) Delisted Pres. Fort Dodge Animal Health 19,998 — — $0 6 2009-04-29

Recent Filings

58 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-12 MRK Notice (144) −11,699 -$1.54M EDGAR
2026-08-12 MRK Sell (S) −45,320 -$5.94M EDGAR
2026-08-11 MRK Notice (144) −12,837 -$1.69M EDGAR
2026-08-10 MRK Notice (144) −20,784 -$2.71M EDGAR
2026-08-10 MRK Sell (S) −6,050 -$788.8K EDGAR
2026-08-06 MRK Notice (144) −6,050 -$788.8K EDGAR
2026-05-07 MRK Grant (A) — $0 EDGAR
2026-05-01 MRK Mixed +1,277 $140.5K EDGAR
2026-02-06 MRK Notice (144) −37,685 -$4.56M EDGAR
2026-02-06 MRK Sell (S) −37,685 -$4.56M EDGAR
Showing 1–10 of 58
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.